Advancing real-world research in thoracic malignancies: learnings from the international I-O Optimise initiative
Søren Paaske Johnsen(Aalborg University), John C. O’Donnell(Bristol-Myers Squibb (Germany)), Gabrielle Emanuel(Bristol-Myers Squibb (United Kingdom)), M. Daumont(Bristol-Myers Squibb (Belgium)), Frank Griesinger(Carl von Ossietzky Universität Oldenburg), Christos Chouaid(Hôpital Intercommunal de Créteil), Isabelle Durand‐Zaleski(Inserm), H.C. Jacobs(Syneos Health (United States)), Jens Benn Sørensen(University of Copenhagen), Maha Muwaffak(IQVIA (United Kingdom)), Robin Munro(IQVIA (United Kingdom)), Minouk J. Schoemaker(Institute of Cancer Research), John R. Penrod(Bristol-Myers Squibb (Germany)), C. Rault
Cited by 3
Related Papers
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
|New England Journal of Medicine|2020|879
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
|JNCI Journal of the National Cancer Institute|2015|570